The self-renewal capability of stem cells, combined with their ability to differentiate into different cell types under programmed conditions, enables improved models for drug discovery and mechanism-based studies of diseases, hence laying the foundation for their therapeutic applications.
The June 2013 issue of APS includes eleven articles that highlight both new findings and emerging ideas in different aspects of stem cell technologies, clinical therapy and drug discovery.
It is evident that stem cell research has evolved from a subject of basic experimental biology to a highly sophisticated, penetrating scientific establishment that is poised to catalyze translational medicine bringing research findings in laboratories to patient benefits in clinic.
For more information please visit http://www.chinaphar.com/1671-4083/34/34(6).htm